ロード中...
IgG Glyco-Engineering to Improve IVIg Potency
Intravenous immunoglobulins (IVIg) are used in the treatment of different autoimmune and inflammatory diseases, such as immune thrombocytopenia and hemolytic anemia. One of the modes of action of IVIg is preventing phagocytosis of autoantibody-opsonized blood cells by saturation of the Fc-gamma rece...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6206079/ https://ncbi.nlm.nih.gov/pubmed/30405631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02442 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|